News Release

CinCor Pharma to Present at Upcoming Piper Sandler and Evercore ISI Investor Conferences

November 22, 2022 at 6:44 PM EST

WALTHAM, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC) today announced that company management will present at the following investor conferences in November:

Event: Piper Sandler 34th Annual Healthcare Conference
Date: November 29December 1, 2022
Location: Lotte New York Palace in New York, New York
Presentation: Tuesday, November 29, 2022 at 1:30pm EST
Webcast: https://event.webcasts.com/starthere.jsp?ei=1585686&tp_key=3261cabcd6
   
Event: Evercore ISI 5th Annual HealthCONx Conference
Date: November 30December 1, 2022
Location: Virtual
Presentation: Thursday, December 1, 2022 at 3:30pm EST
Webcast: https://wsw.com/webcast/evercore29/cinc/2336910

The CinCor management team will participate in one-on-one investor meetings during these events. Investors interested in meeting with CinCor at the conference should contact their Piper Sandler or Evercore ISI representative. An archived replay of the presentations will be available for 90 days at CinCor.com/events.

About CinCor
CinCor, founded in 2018, is a clinical-stage biopharmaceutical company with a mission to bring innovation to the pharmaceutical treatment of cardio-renal diseases. Its lead asset, baxdrostat, a highly selective, oral small molecule inhibitor of aldosterone synthase, is in clinical development for the treatment of hypertension and primary aldosteronism.

Contacts:  Investors:
Michael Kalb Bob Yedid
CinCor Pharma, Inc. LifeSci Advisors
EVP and CFO   ir@CinCor.com

Primary Logo

Source: CinCor Pharma, Inc.